国家神经系统疾病临床医学研究中心数据管理与共享系统
Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Safety and efficacy of intravenous recombinant human prourokinase for acute ischaemic stroke within 4·5 h after stroke onset (PROST-2): a phase 3, open-label, non-inferiority, randomised controlled trial
第一作者：Shuya Li
通讯作者：Yongjun Wang
2024-11-11
已发表文章
主要研究背景及目的
Intra-arterial prourokinase has been shown to be a promising thrombolytic agent in patients with acute ischaemic stroke
方法
Log-binomial regression